Mid Old Cells Hold the Key to Anti Aging

Researchers have discovered mid-old cells, an intermediate stage between youthful and senescent cells, which contribute to aging and inflammation. Targeting these cells with therapies like SLIT2 protein offers a promising new approach to reversing age-related tissue damage and dysfunction.